There are genetic differences that make some people susceptible to meningococcal meningitis and septicemia and leave others immune, according to recently released research.
There are genetic differences that make some people susceptible to meningococcal meningitis and septicemia and leave others immune, according to recently released research.
Medical researchers in London and Singapore say they might have discovered a breakthrough in finding a vaccine for one of the most fatal strains of meningitis.
A lawsuit filed by the Nigerian victims of the 1996 Trovan meningitis vaccine test hit a snag after officials with Federal High Court in Abuja, Nigeria, set aside the service of the court’s processes on Pfizer Specialties.
Nigerian victims of the 1996 Pfizer meningitis Trovan vaccine test announced July 20 that they are suing the company for $384 billion.
The development of a new meningitis vaccine may help prevent epidemics in Africa for the first time.
Officials with GlaxoSmithKline have announced that the U.S. Food and Drug Administration has requested more information about the company’s experimental meningitis vaccine, MenHibrix, before deciding if they will approve it.
LONDON — Pfizer and GlaxoSmithKline signed a landmark 10-year deal March 23 to supply 60 million doses a year of cut-price pneumococcal vaccines to developing nations.
In the wake of an outbreak of meningococcal disease at Oologah-Talala Public Schools, state and local health officials offered free vaccinations to the school system's students and staff, according to the Tulsa World.
BASEL, Switzerland — Novartis announced March 18 that the European Commission granted a marketing authorization for its vaccines against meningococcal disease.
COLUMBUS, Ohio — The seven bacterial meningitis cases at Ohio University the past two years have been declared an outbreak by the U.S. Centers for Disease Control and Prevention, The Columbus Dispatch reported March 7.
Health officials in the west African country of Burkina Faso are worried about an increase in deaths from meningitis which has killed about 250 people so far this year, up from 203 in the same period last year.
CHARLOTTE, N.C. — A new version of the Prevnar childhood vaccine that federal regulators approved Feb. 24 will be partly produced at the company's drug factory in Sanford.
BASEL, Switzerland — The U.S. Food and Drug Administration approved Novartis’ Menveo to prevent meningococcal disease, which infects more than 500,000 people each year, leading to more than 50,000 deaths globally.
Along with rolling out the (five-in-one vaccine to check pneumonia as planned, the union health ministry will launch an impact study in one high-mortality state before deciding on introducing pneumococcal conjugate vaccine as part of the India’s national
ZURICH — Europe's drugs watchdog has recommended approving a meningitis vaccine made by Switzerland's Novartis, according to Reuters.